Navigation Links
Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
Date:9/17/2007

sactions; (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters as well as those related to the integration of Gillette and its subsidiaries), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt, interest rate and commodity cost exposures; (8) the ability to manage continued global political and/or economic uncertainty and disruptions, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (10) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (11) the ability to successfully manage increases in the prices of raw materials used to make the Company's products; (12) the ability to stay close to consumers in an era of increased media fragmentation; and (13) the ability to stay on the leading edge of innovation and maintain a positive reputation on our brands. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

(1) McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340


'/>"/>
SOURCE The Alliance for Better Bone Health
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... ANGELES, Dec. 17 Instacare Corp. (OTC ... life-saving and life-enhancing prescription drugs and diagnostics and ... and a leading developer and provider of e-health ... products announced today that as part of the ... has determined to add two new Directors and ...
(Date:12/17/2009)... Resources, one of the world,s leading research and ... finds that over 70 percent of surveyed U.S. ... diabetes drugs with novel mechanisms of action versus ... need for additional DPP-IV inhibitors. Both surveyed physicians ... ability and physicians in particular say the most ...
(Date:12/17/2009)... N.J., Dec. 17 BASF ... has approved the use of Aseptrol® S10 - ... industrial facilities, such as, schools, hospitals, government buildings, ... S10 - Tab is based on Chlorine dioxide ... delivers a broad spectrum disinfectant as stated ...
Breaking Medicine Technology:Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 2BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 3Valeritas Announces Appointment of New CEO 12391 1Valeritas Announces Appointment of New CEO 12391 2Valeritas Announces Appointment of New CEO 12391 3Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 117 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2
... Micromet, Inc.,(Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune,diseases, presented ... American Association,for Cancer Research (AACR) in San ... levels of subcutaneously administered BiTE(R),antibodies(1). BiTE antibodies ...
... Micromet, Inc.,(Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune,diseases, presented ... Association for,Cancer Research (AACR) in San Diego, ... (Herceptin(R); Genentech, Roche),cetuximab (Erbitux(R); Bristol-Myers Squibb, Imclone, ...
Other Medicine Technology:Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 2Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 3Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 4Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 5Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 3Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 4Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 5
(Date:12/17/2009)... Jerusalem The Hebrew University of Jerusalem Kuvin ... Diseases has received a $5 million grant from ... into visceral leishmaniasis in Ethiopia. , The project ... vector biologist working at the Institute of Medical ... Medicine. , The project, entitled ,Studies on the ...
(Date:12/17/2009)... on our data, the molecular mechanism of infection employed ... Klemens Rottner, head of the HZI research group "Cytoskeleton ... the current issue of the scientific journal " Cellular ... bacteria. They can live in the presence and absence ... ingestion by humans occurs mainly via contaminated egg dishes ...
(Date:12/17/2009)... one day provide therapeutic options for muscle and bone ... the umbilical cord, just as the blood that goes ... disorders, said University of Pittsburgh School of Medicine researchers ... Journal of Biomedicine and Biotechnology . , Umbilical ... are remarkably stable and might not trigger strong immune ...
(Date:12/17/2009)... him a recluse at times, researcher says , , ... researcher claims he has identified the illness that ... nausea, vomiting, headaches and skin problems for most ... physical diagnoses have been suggested for the illness ... become a virtual recluse for periods of time. ...
(Date:12/17/2009)... the aging inequity , , THURSDAY, Dec. 17 ... gender inequity: Women develop more and deeper wrinkles ... do. , The disadvantage had long been suspected, ... said Dr. Foad Nahai, a plastic surgeon practicing ... Surgery Journal . The study appears in the ...
Breaking Medicine News(10 mins):Health News:Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia 2Health News:Invasion without a stir 2Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2Health News:New Theory Emerges on Darwin's Illness 2Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3
... charity Diabetes UK will be withdrawing diabetic food from ... //the disuse of diabetic food which they say are ... ,Squash drinks, chocolates, jam and marmalade specially made ... food stores and pharmacies from today. According to the ...
... have left its impact on the six million care givers in ... because of caring //. ,The survey revealed that only ... GP while 90% of them considered that they should be offered ... that their own health problems affected their ability to care. Besides ...
... as transcendental meditation may decrease blood pressure and ... heart disease, according to a report in the ... one of the JAMA/Archives journals. , ... in India, is taught through a standard protocol ...
... it is found that the survival rate of Hodgkin’s disease ... of the study were published in the journal Cancer. //It ... had the best prognosis. There were significant differences existed between ... malignancy of the lymphatic system of the body, which includes ...
... host a week-long meeting on the Codex Committee on ... , becoming the first Asian host for the meeting ... senior Thai official said. ,Dr. Charal Trinvuthipong, ... 350 delegates from 169 member countries of Codex would ...
... of diabetes has taken on alarming proportions in the last two ... loss of millions of lives, according to a recent study. // ... out that China has the largest number of people with diabetes ... over followed by India with with 30 million people affected by ...
Other Medicine News:Health News:Care Workers Need Some Care Too 2Health News:Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease 2Health News:HD Type Plays an Important Role in the Survival of the Patient 2
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
Electric high speed system....
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....
Prevents formation of microscopic ice crystals and sample distortion caused by slow freezing of hyperosmolar tissue samples in conventional cyrostats....
Medicine Products: